• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

肥胖受试者皮下脂肪组织中的体内α(1)-肾上腺素能脂肪分解活性

In vivo alpha(1)-adrenergic lipolytic activity in subcutaneous adipose tissue of obese subjects.

作者信息

Flechtner-Mors M, Jenkinson C P, Alt A, Adler G, Ditschuneit H H

机构信息

Department of Internal Medicine, University of Ulm, Germany.

出版信息

J Pharmacol Exp Ther. 2002 Apr;301(1):229-33. doi: 10.1124/jpet.301.1.229.

DOI:10.1124/jpet.301.1.229
PMID:11907178
Abstract

The role of alpha(1)-adrenoceptors in lipid mobilization and blood flow was investigated in situ using microdialysis of subcutaneous adipose tissue in severely obese subjects. The lipolysis rate was assessed by determination of interstitial glycerol concentration. The alpha(1)-adrenoceptor agonist norfenefrine caused an increase in glycerol level in adipose tissue that was similar to that observed with the physiologic alpha(1,2)-beta(1)-adrenoceptor agonist norepinephrine, whereas the alpha(1)-adrenoceptor antagonist urapidil showed no effect on basal lipolysis rate. However, the enhanced glycerol concentration due to norfenefrine and norepinephrine was suppressed in the presence of urapidil. The beta-adrenoceptor antagonist propranolol showed no effect on norfenefrine-stimulated glycerol outflow. Blood flow was assessed using the ethanol escape technique. Perfusion with norfenefrine decreased blood flow, whereas urapidil enhanced blood flow significantly. Despite the increase in blood flow, the basal interstitial glycerol concentration remained unchanged. Although norfenefrine at high concentrations could inhibit the urapidil-induced increase in blood flow, the norfenefrine-induced glycerol output was not affected. These results demonstrate that alpha(1)-adrenoceptors are involved in regulation of lipolysis rate and microcirculation of adipose tissue. However, the observed changes in local blood flow were not related to glycerol output.

摘要

利用微透析技术对重度肥胖受试者的皮下脂肪组织进行原位研究,以探讨α(1)-肾上腺素能受体在脂质动员和血流中的作用。通过测定间质甘油浓度来评估脂肪分解率。α(1)-肾上腺素能受体激动剂去甲伪麻黄碱可使脂肪组织中的甘油水平升高,这与生理性α(1,2)-β(1)-肾上腺素能受体激动剂去甲肾上腺素所观察到的情况相似,而α(1)-肾上腺素能受体拮抗剂乌拉地尔对基础脂肪分解率无影响。然而,在乌拉地尔存在的情况下,去甲伪麻黄碱和去甲肾上腺素所致的甘油浓度升高受到抑制。β-肾上腺素能受体拮抗剂普萘洛尔对去甲伪麻黄碱刺激的甘油流出无影响。采用乙醇洗脱技术评估血流。用去甲伪麻黄碱灌注可使血流减少,而乌拉地尔可显著增加血流。尽管血流增加,但基础间质甘油浓度保持不变。虽然高浓度的去甲伪麻黄碱可抑制乌拉地尔诱导的血流增加,但去甲伪麻黄碱诱导的甘油输出不受影响。这些结果表明,α(1)-肾上腺素能受体参与脂肪组织脂肪分解率和微循环的调节。然而,观察到的局部血流变化与甘油输出无关。

相似文献

1
In vivo alpha(1)-adrenergic lipolytic activity in subcutaneous adipose tissue of obese subjects.肥胖受试者皮下脂肪组织中的体内α(1)-肾上腺素能脂肪分解活性
J Pharmacol Exp Ther. 2002 Apr;301(1):229-33. doi: 10.1124/jpet.301.1.229.
2
Sympathetic regulation of glucose uptake by the alpha1-adrenoceptor in human obesity.
Obes Res. 2004 Apr;12(4):612-20. doi: 10.1038/oby.2004.70.
3
Sympathetic nervous system activity and anti-lipolytic response to iv-glucose load in subcutaneous adipose tissue of obese and obese type 2 diabetic subjects.肥胖和肥胖2型糖尿病受试者皮下脂肪组织中交感神经系统活性及对静脉注射葡萄糖负荷的抗脂解反应
PLoS One. 2017 Mar 27;12(3):e0173803. doi: 10.1371/journal.pone.0173803. eCollection 2017.
4
Studies of phosphodiesterase effects on adipose tissue metabolism in obese subjects by the microdialysis technique.
J Physiol Pharmacol. 2005 Sep;56(3):355-68.
5
Microdialysis assessment of local adipose tissue lipolysis during beta-adrenergic stimulation in upper-body-obese subjects with type II diabetes.对患有II型糖尿病的上身肥胖受试者进行β-肾上腺素能刺激期间局部脂肪组织脂解的微透析评估。
Clin Sci (Lond). 1999 Oct;97(4):421-8. doi: 10.1042/cs0970421.
6
Microdialysis of adipose tissue during surgery: effect of local alpha- and beta-adrenoceptor blockade on blood flow and lipolysis.手术期间脂肪组织的微透析:局部α和β肾上腺素能受体阻断对血流和脂肪分解的影响。
J Clin Endocrinol Metab. 1996 Aug;81(8):2919-24. doi: 10.1210/jcem.81.8.8768852.
7
Stimulation of adipose tissue lipolysis following insulin-induced hypoglycaemia: evidence of increased beta-adrenoceptor-mediated lipolytic response in IDDM.胰岛素诱导的低血糖后脂肪组织脂解的刺激:胰岛素依赖型糖尿病中β-肾上腺素能受体介导的脂解反应增强的证据。
Diabetologia. 1996 Jul;39(7):845-53. doi: 10.1007/s001250050519.
8
In situ assessment of the role of the beta 1-, beta 2- and beta 3-adrenoceptors in the control of lipolysis and nutritive blood flow in human subcutaneous adipose tissue.β1、β2和β3肾上腺素能受体在人体皮下脂肪组织脂肪分解和营养性血流控制中作用的原位评估
Br J Pharmacol. 1996 Mar;117(5):907-13. doi: 10.1111/j.1476-5381.1996.tb15279.x.
9
Demonstration of an in vivo functional beta 3-adrenoceptor in man.人体内功能性β3 - 肾上腺素能受体的证实。
J Clin Invest. 1995 May;95(5):2239-45. doi: 10.1172/JCI117914.
10
Activation of alpha(2)-adrenergic receptors impairs exercise-induced lipolysis in SCAT of obese subjects.α₂-肾上腺素能受体的激活会损害肥胖受试者皮下脂肪组织中运动诱导的脂肪分解。
Am J Physiol Regul Integr Comp Physiol. 2000 Aug;279(2):R499-504. doi: 10.1152/ajpregu.2000.279.2.R499.

引用本文的文献

1
Current Developments on the Role of α-Adrenergic Receptors in Cognition, Cardioprotection, and Metabolism.α-肾上腺素能受体在认知、心脏保护和代谢中的作用的当前进展
Front Cell Dev Biol. 2021 May 25;9:652152. doi: 10.3389/fcell.2021.652152. eCollection 2021.
2
Targeting Adrenergic Receptors in Metabolic Therapies for Heart Failure.靶向治疗心力衰竭的代谢疗法中的肾上腺素能受体。
Int J Mol Sci. 2021 May 28;22(11):5783. doi: 10.3390/ijms22115783.
3
Sympathetic nervous system activity and anti-lipolytic response to iv-glucose load in subcutaneous adipose tissue of obese and obese type 2 diabetic subjects.
肥胖和肥胖2型糖尿病受试者皮下脂肪组织中交感神经系统活性及对静脉注射葡萄糖负荷的抗脂解反应
PLoS One. 2017 Mar 27;12(3):e0173803. doi: 10.1371/journal.pone.0173803. eCollection 2017.
4
Regulation of human subcutaneous adipose tissue blood flow.人体皮下脂肪组织血流的调节。
Int J Obes (Lond). 2014 Aug;38(8):1019-26. doi: 10.1038/ijo.2013.200. Epub 2013 Oct 29.
5
Pharmacogenetics of antipsychotic-induced weight gain.抗精神病药物所致体重增加的药物遗传学
Psychopharmacology (Berl). 2004 Aug;174(4):477-89. doi: 10.1007/s00213-004-1949-9. Epub 2004 Jul 8.